The Biodesix Access Program provides comprehensive financial assistance, insurance navigation, and flexible billing options to ensure that patients can access critical diagnostic testing without facing prohibitive out-of-pocket costs. The initiative assists patients with insurance verification, prior authorizations, claims appeals, interest-free payment plans, and specialized financial hardship grants for those who qualify based on income guidelines. By alleviating financial barriers, the program aims to make advanced genomic and blood-based lung cancer tests widely accessible to patients regardless of their financial circumstances.